Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fanconi Anemia, Complementation Group D1 × iniparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Triple Negative Breast Neoplasms 2 Recurrence 2 Ovarian Neoplasms 2 Neoplasms 2 Hypersensitivity 2 Breast Neoplasms 2 Neoplasm Metastasis 1 Fanconi Anemia, Complementation Group D1 1 Carcinoma, Non-Small-Cell Lung 1 Breast Cancer Female 1

Interventions

olaparib 5 pembrolizumab 1 liposomal doxorubicin 1 iniparib 1 Trabectedin 1 Paclitaxel 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00677079 2013-10-01

Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Sanofi

Phase 2 Completed

Classical hematology

Fanconi Anemia, Complementation Group D1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡